The Latest Breaking News from Disease

RL:Souths hardman retires due to MND diagnosis

Jai Arrow's decade-long NRL career has come to an end after the South Sydney forward was diagnosed with motor neurone disease.

AAP · May 20

'Can't believe it': Souths star suffering from MND

Jai Arrow's decade-long NRL career has come to an end after the South Sydney forward was diagnosed with motor neurone disease.

AAP · May 20

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the company’s initial development focus while also discussing ongoing work in non-muscle invasive bladde

MarketBeat · May 20

Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances

Agios Pharmaceuticals (NASDAQ:AGIO) executives said the company is focused on advancing mitapivat across rare hematologic diseases, highlighting early launch traction in thalassemia and a recently submitted supplemental new drug application for sickle cell disease during a presentation at the 2026 R

MarketBeat · May 19

ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide updates on commercial trends for NUPLAZID and DAYBUE, and discuss selected pipeline and business develo

MarketBeat · May 19

Forget blood tests, your cell's sugar coat may be the earliest cancer signal we have ever found

A new study shows that over 90% of cancer cases begin with subtle cellular changes before symptoms appear. Scientists now highlight hidden sugar patterns on human cells cancer early detection as a powerful breakthrough in diagnostics. These microscopic glycocalyx sugar shifts act like biological signals of disease. Researchers say advanced…

The Economic Times · May 19

As WHO sounds alarm over Ebola in DRC, what can be learned from previous outbreaks?

Conflict, mistrust and delayed detection could complicate response to emergency caused by Bundibugyo variant

The Guardian - UK · May 19

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients…

AAP · May 19

Common Cleaning Solvent May Triple Risk of Serious Liver Disease

New study links common cleaning solvent PCE to a tripled risk of serious liver scarring, highlighting hidden household and workplace exposure and urging stricter safety and screening.

Medical Daily · May 19

Congo reports more Ebola cases as WHO expresses concern over scale and speed of the outbreak

The Congolese health ministry is reporting that there have been at least 131 deaths and over 500 suspected cases in the ongoing Ebola outbreak in eastern Congo

The Independent UK · May 19